A144510 logo

GC Cell Corporation Stock Price

KOSDAQ:A144510 Community·₩400.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A144510 Share Price Performance

₩26,650.00
2000.00 (8.11%)
₩26,650.00
2000.00 (8.11%)
Price ₩26,650.00

A144510 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Mediocre balance sheet with low risk.

3 Risks
0 Rewards

GC Cell Corporation Key Details

₩170.1b

Revenue

₩141.4b

Cost of Revenue

₩28.7b

Gross Profit

₩126.9b

Other Expenses

-₩98.2b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-6.53k
16.88%
-57.72%
16.2%
View Full Analysis

About A144510

Founded
2011
Employees
698
CEO
Jai-Wang Kim
WebsiteView website
www.gccell.com

GC Cell Corporation develops cell therapy products. It also provides cell banking, sample inspection, clinical trial, and bio logistics services. Its main product is Immuncell-LC. GC Cell Corporation has strategic agreement with Lukas Biomedical Co., Ltd. to develop Cell therapy. The company was formerly known as Green Cross Lab Cell Corporation and changed its name to GC Cell Corporation in November 2021. GC Cell Corporation was founded in 2011 and is based in Yongin-si, South Korea.